🇪🇺 Cellcept in European Union

EMA authorised Cellcept on 14 February 1998

Marketing authorisation

EMA — authorised 14 February 1998

  • Marketing authorisation holder: Roche Registration GmbH
  • Status: approved

Cellcept in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Cellcept approved in European Union?

Yes. EMA authorised it on 14 February 1998.

Who is the marketing authorisation holder for Cellcept in European Union?

Roche Registration GmbH holds the EU marketing authorisation.